1'758 companies found
Pattern BioSciences GmbH
Basel · Since 2018
The core activity of Pattern Biosciences is the development of DNA computers designed to cure complex diseases such as cancer. To achieve this, the company develops therapeutic candidates based on a systematic design and testing method to create targeted and safe medicines. These medicines are intended to combat diseases at their root by acting at the molecular level and selectively eliminating or reprogramming cells.
PDC Therapeutics SA
Epalinges · Since 2020
The core activity of PDC Therapeutics is the development of targeted polymer-drug conjugate technologies and smart nanomedicines for targeted therapies, particularly using the proprietary Sagitta biodegradation platform, to offer patients an optimal therapeutic ratio.
Pearsceuticals AG
Hergiswil Nw · Since 2015
Pearsceuticals AG develops and markets pharmaceuticals, nutritional supplements and cosmetics. It uses proprietary formulas focused on dermatology, paediatrics and gynecology, oversees GMP-compliant production with partners such as Fagron, and provides marketing and distribution support for its product portfolio.
PeptART Bioscience GmbH
Läufelfingen · Since 2015
PeptART Bioscience GmbH manufactures a range of amino acid derivatives, pseudoproline building blocks and peptides and supplies these products worldwide. The company offers custom synthesis and supplies materials as API starting materials, and it holds ISO 9001:2015 certification.
Perseo pharma AG
Muttenz · Since 2019
The core activity of Perseo Pharma AG is the development of enzyme replacement therapies for the treatment of metabolic diseases, in particular for rare diseases such as exocrine pancreatic insufficiency, congenital sucrase-isomaltase deficiency and maple syrup urine disease. The company develops innovative therapies based on the enzzen platform technology and focuses on the clinical development of active ingredients for the treatment of these diseases.
Pfanstiehl GmbH
Zug · Since 2015
Pfanstiehl is a specialist in the manufacture of high-purity, endotoxin-free, metal-free injectable cGMP excipients and biopharmaceutical components for various applications in bioprocessing, formulation, and specialty research. The company also offers custom API manufacturing, custom ADC linker synthesis, and other services. The core activity of the company is the development and manufacture of high-quality excipients for the biopharma and pharmaceutical industries, particularly for the production of vaccines and medicines.
P&G MedChem AG
Köniz · Since 2003
The core activity of P&G MedChem AG is the development, manufacture and distribution of products and solutions for the healthcare and chemical industries, including: health products (cosmetics, hygiene products, perfumes, chemicals, pharmaceutical active ingredients), medical devices (e.g. dialysis machines), raw materials for the cosmetics and pharmaceutical industries, fragrances for cosmetics and perfumes, and industrial machinery for the healthcare industry. The company also offers services such as documentation, export and logistics.
ph. AG
Zurich · Since 2016
PharConSwiss GmbH
Winkel · Since 2019
The core activity of PharConSwiss GmbH is the consulting and distribution of dietary supplements, in particular those based on saffron, which are used to maintain a positive mood and improve concentration and attention.
PHARGENTIS SA
Barbengo · Since 2015
The core activity of Phargentis SA is the virtual development of pharmaceuticals, in particular the development of complex dosage forms for generics and innovative SuperGenerics products, as well as the licensing of these products to leading pharmaceutical companies worldwide.
PharmaBlock Sciences (Switzerland) AG
Horgen · Since 2024
PharmaBlock Sciences (Switzerland) AG provides chemistry products and R&D and CDMO services for pharmaceutical drug discovery and manufacturing. Its services include building blocks, chemistry research, development and GMP manufacturing of APIs and drug products, and low‑carbon technologies such as continuous flow chemistry.
Pharmacie des hôpitaux du Nord vaudois et de la Broye (PHNVB)
Yverdon-Les-Bains · Since 1998
The core activity of the company "Pharmacie des Hôpitaux du Nord vaudois" (PHNVB) consists of the manufacture and distribution of pharmaceutical products, in particular: * Manufacture of sterile and non-sterile products * Preparation of cytostatics * Pharmaceutical support and clinical pharmacy * Research and development in the field of pharmacy The company is part of the healthcare system and works closely with the Hôpitaux du Nord vaudois to provide patients with the necessary medications and pharmaceutical services.
PharmaCina - DHAO SA
Losone · Since 2000
The core activity of PharmaCina DHAO SA is the manufacture and distribution of traditional Chinese medicine products. The company operates a laboratory where it prepares magistral preparations and offers these products through its website and possibly through other distribution channels.
Pharmacros SA
Geneva · Since 2019
The core activity of Pharmacros is the development, production and distribution of high-quality dietary supplements and wellness products, particularly based on collagen, in compliance with ISO and GMP standards.
Pharmact Holding AG
Baar · Since 1988
The core activity of Pharmact AG is the development and application of innovative medical solutions, particularly in the areas of atherosclerosis, diabetes mellitus, and severe liver diseases. The company develops genetically optimized enzymes and point-of-care tests (POCT) for the diagnosis and treatment of diseases, such as familial hypercholesterolemia. The core activity also includes research and development of new therapies and prevention products, as well as the commercial marketing of these products.
PharmaMar AG
Basel · Since 2001
The core activity of PharmaMar is the development and marketing of cancer drugs, particularly marine-derived oncology therapies. The company researches and develops innovative treatments for cancer patients and offers products such as Yondelis, Zepzelca and Aplidin.
Pharma Medica AG
Roggwil Tg · Since 2001
The core activity of Pharma Medica AG is the distribution of medical products, dietary supplements and cosmetics. The company operates as a pharmaceutical service provider and offers a wide range of products based on an optimal blend of naturalness and quality to achieve sustainable efficacy.
PHARMA TICINO SA
Taverne · Since 2014
The core activity of Pharmaticino SA is to advise and support pharmaceutical companies in the development and marketing of medicines, particularly in the region south of the Alps. This also includes providing services in the healthcare sector, such as setting up medical studies, fitness and pharmacy offers.
Pharmatrans Sanaq AG
Allschwil · Since 1982
The core activity of Pharmatrans SANAQ AG is the development, manufacture and distribution of excipients and active ingredients for the pharmaceutical industry. The company offers standardized and customer-specific solutions and supports its customers in the development and production of medicinal products.
PharmaWiki GmbH
Disentis/Mustér · Since 2009
The core activity of Mepha is the development, manufacture and distribution of generics and pharmaceuticals, particularly in Switzerland. The company offers a wide range of medications, including effervescent tablets, tablets and other dosage forms, and focuses on the areas of dermatology, allergology and infectiology.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register